Public Health Emergency: SOLIDARITY TRIAL Philippines

NACompletedINTERVENTIONAL
Enrollment

1,314

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

April 17, 2021

Study Completion Date

April 17, 2021

Conditions
Covid19
Interventions
DRUG

Remdesivir

Two intravenous loading doses, then daily infusion for 10 days

DRUG

Hydroxychloroquine

Two oral loading doses, then orally twice daily for 10 days

DRUG

Lopinavir / Ritonavir

Orally twice daily for 14 days

DRUG

Interferon beta-1a

Daily injection for 6 days

DRUG

Acalabrutinib

Orally twice daily for 10 days

Trial Locations (25)

Unknown

Baguio General Hospital, Baguio City

Cebu Doctor's University Hospital, Cebu City

Perpetual Succor Hospital Cebu, Cebu City

Vicente Sotto Memorial Medical Center, Cebu City

Southern Philippines Medical Center, Davao City

West Visayas University Medical Center, Iloilo City

St Luke's Medical Center Global, City of Taguig

Makati Medical Center, Makati City

Chinese General Hospital, Manila

Manila Doctors Hospital, Manila

ManilaMed - Medical Center Philippines, Manila

San Lazaro Hospital, Manila

UP - Philippine General Hospital, Manila

Asian Hospital and Medical Center, Muntinlupa

Research Institute for Tropical Medicine, Muntinlupa

San Juan de Dios Educational Foundation Inc - Hospital, Pasay

The Medical City, Pasig

Diliman Doctors Hospital, Quezon City

Fe Del Mundo Medical Center, Quezon City

Lung Center of the Philippines, Quezon City

St Luke's Medical Center Quezon City, Quezon City

University of the East Ramon Magsaysay Memorial Medical Center, Quezon City

World Citi Medical Center, Quezon City

Cardinal Santos Medical Center, San Juan City

Batangas Medical Center, Batangas

All Listed Sponsors
lead

University of the Philippines

OTHER

NCT05024006 - Public Health Emergency: SOLIDARITY TRIAL Philippines | Biotech Hunter | Biotech Hunter